CTRI/2024/02/062693尚未招募Unknown
PRIMARY OBJECTIVE: To evaluate and compare the in-vivo efficacy and safety of two skin regimes in terms of reduction in dark spots (Lightens the pigmentation of selected dark spots-age spots), improvement in skin moisturization upto 48 hours, improvement in skin brightening , improvement in skin firmness, elasticity, skin radiance, skin glow, skin softness, prevention of water loss from skin (TEWL parameter) and tan reduction, reduction in fine line and wrinkles and clear skin in terms of reduction in dark spot and on healthy female subjects.SECONDARY OBJECTIVE: To evaluate the subject feedback for product efficacy in terms of clear skin (basis reduction in dark spots) - NI
Incnut Lifestyle Retail Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Indian female subjects
- •2)Having dry skin.
- •3)Having normal skin type with Age Related Dark Spots.
- •4)Having dull and tanned skin.
排除标准
- •1)Being pregnant or breastfeeding or having stopped to
- •breastfeed in the past three months.
- •2)Having refused to give her
- •assent by signing the consent form.
- •3)Taking part in another study liable to interfere with this study.
- •4)Being insulin-dependent diabetic or non insulin-dependent diabetic
- •with a recent therapy (less than 6 months)
- •5)Having a progressive asthma (either under treatment or last fit in
- •the last 2 years)
- •6)Being epileptic
- •7)Having non stabilized thyroid problems (requirement of a stabilized
- •treatment for at least 6 months)
- •8)Having cutaneous hypersensitivity
- •9)Having a diagnosed or highly probable allergy to one or several
- •compounds of the cosmetic products or food products or to latex
- •10) Following a chronic medicinal treatment comprising any of the
- •following products: aspirin-based products, anti-inflammatories,
- •anti-histamines, corticotherapy, taken by general or local routes (the
- •only medication permitted is paracetamol)
- •11)Having undergone a surgery requiring a general anaesthetic of
- •more than one hour in the past 6 months.
- •12)Having changed her cosmetic habits in the 14 days preceding the
- •start of the study on the studied anatomic unit
- •13)Having applied a cosmetic product (included make-up) on the
- •studied areas the first day of the study (only face cleaned with water
- •is accepted).
研究者
相似试验
进行中（未招募）
不适用
The primary objective of this study is to compare the analgesic efficacy and the safety of ABT-894 (6 mg tablets) administered twice daily (BID) to placebo in the treatment of diabetic neuropathic pain (DNP).Additionally, this study will also explore the pharmacokinetic and pharmacogenetic characteristics of ABT-894 in the DNP population. - NDdiabetic neuropathic painMedDRA version: 6.1Level: PTClassification code 10054095EUCTR2007-001140-47-ITAbbott GmbH & Co. KG110
已完成
不适用
Evaluation of safety & Efficacy of skin care formulatioCTRI/2022/06/043455Transformative Learning Solution Pvt Ltd35
已完成
不适用
Assessment of safety & Efficacy of cosmetic productCTRI/2023/02/050012Transformative Learning Solution Pvt Ltd32
已完成
不适用
Evaluation of safety of productCTRI/2022/05/042477Transformative Learning Solution Pvt Ltd120
尚未招募
Unknown
Assessment of safety of cosmetic productCTRI/2023/09/057658Transformative Learning Solution Pvt Ltd